These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 6577468

  • 1. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK, Rao AK, Willis J, Colman RW.
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD, Venton DL, Le Breton GC.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 9. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS, Kim HM, Lee KS, Khil LY, Mar WC, Ryu CK, Moon CK.
    Biochem Pharmacol; 1997 Jul 15; 54(2):259-68. PubMed ID: 9271330
    [Abstract] [Full Text] [Related]

  • 10. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH, Kuo SC, Huang LJ, Huang TF, Teng CM.
    Thromb Res; 1992 Apr 01; 66(1):61-73. PubMed ID: 1412184
    [Abstract] [Full Text] [Related]

  • 11. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF, Anderson WH, Smith JB, Chuang HY, Mason RG.
    Am J Pathol; 1981 Aug 01; 104(2):132-41. PubMed ID: 7258300
    [Abstract] [Full Text] [Related]

  • 12. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE, Kochel PJ, Saussy DL, Halushka PV.
    Mol Pharmacol; 1985 Aug 01; 28(2):163-9. PubMed ID: 2991736
    [Abstract] [Full Text] [Related]

  • 13. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 01; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 14. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP, Maguire MH.
    Br J Pharmacol; 1984 May 01; 82(1):61-72. PubMed ID: 6428500
    [Abstract] [Full Text] [Related]

  • 15. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD, Venton DL, Le Breton GC.
    Am J Physiol; 1985 Jul 01; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [Abstract] [Full Text] [Related]

  • 16. Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.
    Gross PL, Rand ML, Barrow DV, Packham MA.
    Arterioscler Thromb; 1991 Jul 01; 11(3):610-6. PubMed ID: 2029501
    [Abstract] [Full Text] [Related]

  • 17. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity.
    Hirakata H, Ushikubi F, Toda H, Nakamura K, Sai S, Urabe N, Hatano Y, Narumiya S, Mori K.
    Anesthesiology; 1996 Dec 01; 85(6):1447-53. PubMed ID: 8968193
    [Abstract] [Full Text] [Related]

  • 18. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
    Banerjee D, Mazumder S, Sinha AK.
    Blood Coagul Fibrinolysis; 2014 Sep 01; 25(6):585-91. PubMed ID: 25083729
    [Abstract] [Full Text] [Related]

  • 19. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar, Anwer K.
    Thromb Res; 1986 Feb 15; 41(4):555-66. PubMed ID: 3961734
    [Abstract] [Full Text] [Related]

  • 20. Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder.
    Lages B, Malmsten C, Weiss HJ, Samuelsson B.
    Blood; 1981 Mar 15; 57(3):545-52. PubMed ID: 7459434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.